Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition - New Report by Koncept Analytics - PowerPoint PPT Presentation


PPT – Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition - New Report by Koncept Analytics PowerPoint presentation | free to download - id: 7f2441-NTUyM


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition - New Report by Koncept Analytics


As per the “Global IVD market report”, market segments such as blood glucose monitoring. For more mail: – PowerPoint PPT presentation

Number of Views:21


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition - New Report by Koncept Analytics

Global In-Vitro Diagnostics (IVD) Market Report
----------------------------------------- 2015
View Report Details
View Report Details
  • Executive Summary
  • The diagnostic industry is widely classified into
    two types In-vitro diagnostics and In-vivo
    diagnostics. In-vitro tests are executed in glass
    test tubes, while In-vivo diagnostics tests are
    executed inside a patients body. IVD products
    are indeed designed and produced for collecting
    samples derived from the patients body and
    scrutinizing them outside, which are commonly
    conducted in hospitals, clinics and labs and in
    personal settings. Apart from the application of
    IVDs in medical diagnosis and health screening
    such as checking blood of signs for infections,
    or urine for the presence of glucose, they are
    also used in genetic testing, genomics,
    veterinary diagnostics, food testing,
    environmental testing, and research.
  • As per the Global IVD market report, market
    segments such as blood glucose monitoring and
    clinical chemistry are relatively mature and
    stable. However, with growing personalized
    medical treatment trend, molecular diagnostics
    market is expected to grow significantly with
    strict regulatory measures.
  • The key factors driving the market growth apart
    from generic macro-economic factors include
    accelerating diabetic population, increasing
    sales of medical technological devices,
    increasing complexity of diseases, and
    development of cardiac troponin assays. Some of
    the noteworthy trends observed in the industry
    are newly growing vitamin D testing market,
    genome sequencing market, usage of companion
    diagnostics in oncology, and increased importance
    of diagnostics. However, the industry remains
    exposed to certain challenges such as narrow
    economic moats in diagnostic market,
    reimbursement issues in clinical laboratory
    services, laboratory-developed tests waning IVD
    profits, and government regulation for IVD tests
    and stringent in genetic based tests.
  • The report provides a comprehensive study of
    global in-vitro diagnostic market covering
    regional markets and major segments. The
    competition in the global in-vitro diagnostic
    market is highly amalgamated with large players
    like Abbott, Siemens, Roche and Johnson and
    Johnson. All these companies have been profiled
    in the present report highlighting their key
    financials and business strategies for their long
    term growth.
  • By combining SPSS Inc.s data integration and
    analysis capabilities with our relevant findings,
    we have predicted the future growth of the
    industry. We employed various significant
    variables that have an impact on this industry
    and created regression models with SPSS Base to
    determine the future direction of the industry.
    Before deploying the regression model, the
    relationship between several independent or
    predictor variables and the dependent variable
    was analyzed using standard SPSS output,
    including charts, tables and tests.

Illumina has the largest market share in the
genome sequencing market
  • By region, North America is the largest market
    which accounted for .. of total IVD market,
    followed by EMEA (Europe/Middle East/Africa) with
    of market share in 2014. Asia-Pacific, Japan
    and Latin America accounted for .., .. and
    of the market share respectively.
  • In 2014, the global sales of in-vitro diagnostic
    medical technology amounted to US... billion, up
    by .. from US... billion in 2013. In-vitro
    diagnostic devices have remained to be one of the
    most important and strongest segments of medical
    technology sales for past many years.
  • The top three IVD segments by Technology type,
    i.e. self-monitoring blood glucose, clinical
    chemistry and immunodiagnostics, collectively
    account for more than of the total IVD market
    in 2014. Molecular diagnostics accounts for ..
    of the IVD market. Moreover, point-of-care,
    hematology and microbiology account for .. of
    IVD market share each.

Global IVD Market by Geography (2014)
Global In-Vitro Diagnostic Device Sales
Global IVD Market Share by Technology Type (2014)
For Vitamin D testing, two laboratory tests for
vitamin D are available - 25-hydroxy vitamin D
and 1,25-dihydroxyvitamin D.
Global Clinical and Industrial In-Vitro Market
Value (2011-2014)
  • Global in-vitro diagnostic market has been
    broadly segmented into clinical and industrial
    in-vitro market segment, of which clinical
    in-vitro market is valued at US... billion while
    industrial in-vitro market is valued at US...
    billion in 2014.
  • Laboratory tests made up about .. of the total
    IVD market in 2014. Most of the IVD testing worth
    is performed in laboratories defined as hospital
    labs and independent labs such as private
    reference labs and blood bank labs.
  • By product type, IVD industry is classified into
    three categories among which Reagents/Chemistry
    makes up majority of the market of about ...
    Instrumentation and Instrument Services holds ..
    and .. of the market in 2014, respectively.

Global IVD Market by Test Location (2014)
Global IVD Market Share by Product Type (2014)
The Chinese government gives priority to
healthcare reforms and healthcare investments.
Global Molecular Diagnostic Market Value
  • The estimated US... billion molecular diagnostic
    market (MDx) is the fastest-growing segment of
    the IVD industry. Since 2009, there is an overall
    growth of in this segment, which is further
    estimated to become a US.. billion market by
  • Except the UK, in 2014, in terms of USD, European
    IVD market witnessed a growth of , to reach
    US... billion (EUR billion) as compared to
    US... billion (EUR billion) in 2013.
  • Chinese IVD market is growing at a staggering
    CAGR of , to reach US... million by 2018 from
    current market value of US... million in 2014.
    China is expected to witness growth in IVD
    industry as immunochemistry market is blossoming
    because of their favorable demographics and large
    underpenetrated population.

IVD Market Value in EU27 EFTA (2009-2014)
IVD Market Value in China (2009-2018E)
In-vitro diagnostics is one of the strongest and
largest segment within medical technology.
Global In Vitro Diagnostics Market Value Forecast
  • The in-vitro diagnostics (IVD) industry is one of
    the strongest segments within the healthcare
    industry. The global IVD market is forecasted to
    grow by to reach US... billion in 2015,
    compared to US... billion in 2014. The market is
    forecasted to reach US... billion by the end of
    2020 at a CAGR of from 2014 to 2020.
  • Increasing complexity of diseases and need for
    better diagnosis for effective treatment has led
    to the growth of IVD market within healthcare
    industry. Some IVD market segments such as blood
    glucose monitoring and clinical chemistry are
    relatively mature, while molecular diagnostics
    market growth is likely to improve ease of access
    to personalized medical treatments. In
    particular, new companion diagnostic tests demand
    is expected to emerge as pharmaceutical and
    biotech companies are inclined to shift their
    pipelines toward such beset therapies. Along with
    genome sequencing this segment seems to be a
    disruptive and high-growth area that comprises
    greater genetic screening within cancer diagnosis
    and treatments, prenatal and newborn screening,
    and rare diseases.

Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
In-Vitro Diagnostics (IVD) Market . To know more
about this report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
Vikas Gupta BD Manager